Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TIGD5 Activators

The chemical class known as TIGD5 Activators encompasses a diverse group of compounds that are recognized for their ability to influence gene expression and cellular signaling pathways, which can lead to the activation of TIGD5. These activators are not linked by a common chemical structure but rather by the functional outcome of their interaction with cellular processes. The activators operate through various mechanisms such as the inhibition of DNA methyltransferases, histone deacetylases (HDACs), tyrosine kinases, phosphodiesterases, and other key enzymes or pathways that manage the intricate regulation of gene expression and chromatin remodeling. By modulating the activity of these enzymes or signaling pathways, the activators can alter the epigenetic landscape or the cellular signaling milieu, which can result in changes to the expression and function of a range of proteins including TIGD5.

The modulation of epigenetic markers is a central theme among TIGD5 Activators, as they can alter the methylation status of DNA and the acetylation of histones, thereby influencing the transcriptional potential of genes that are implicated in the function of TIGD5. Similarly, the alteration of cellular signal transduction cascades by these compounds can lead to a cascade of intracellular events that culminate in the modification of gene expression profiles. The diversity in the structure of TIGD5 Activators reflects the complexity and the multiplicity of the pathways they affect. The changes induced by these activators in the cellular environment are crucial for understanding how TIGD5 can be activated, offering insights into the modulation of this protein's activity without direct interaction with the protein itself.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

HDAC inhibitor that increases acetylation levels, enhancing the expression of genes that could be associated with TIGD5.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

DNA methyltransferase inhibitor that prevents DNA methylation, affecting gene expression profiles linked to TIGD5.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Hypomethylating agent that modifies DNA methylation, altering the expression of TIGD5-related genes.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Tyrosine kinase inhibitor that alters cellular signaling, leading to changes in gene expression including genes interacting with TIGD5.

Resveratrol

501-36-0sc-200808
sc-200808A
sc-200808B
100 mg
500 mg
5 g
$80.00
$220.00
$460.00
64
(2)

Influences sirtuin activity and impacts histone and DNA modification, altering the expression of TIGD5 related genes.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Aldehyde dehydrogenase inhibitor that can modulate various cellular pathways, affecting TIGD5 through proteostasis alterations.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Phosphodiesterase inhibitor that elevates cAMP levels, affecting signaling pathways that intersect with TIGD5 function.

Parthenolide

20554-84-1sc-3523
sc-3523A
50 mg
250 mg
$81.00
$306.00
32
(2)

NF-κB pathway inhibitor that modifies the expression of inflammatory response genes, altering TIGD5-related signaling.

Mocetinostat

726169-73-9sc-364539
sc-364539B
sc-364539A
5 mg
10 mg
50 mg
$214.00
$247.00
$1463.00
2
(1)

HDAC inhibitor that may change gene expression profiles, influencing genes that work in tandem with TIGD5.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

Selective HDAC inhibitor that can modulate gene expression, affecting pathways involving TIGD5.